J. Gilmore

发表

Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).

E. Lunney, J. Rubin, R. Talanian, 2010, Bioorganic & medicinal chemistry letters.

Inhibition of interleukin-1beta converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones.

E. Lunney, D. Downing, J. Warmus, 2010, Bioorganic & medicinal chemistry letters.

A molecular modeling analysis of novel non-hydroxamate inhibitors of TACE.

Andrew Tebben, Zelda R Wasserman, A. Tebben, 2007, Bioorganic & medicinal chemistry letters.

Synthesis and structure–activity relationship of a novel, non-hydroxamate series of TNF-α converting enzyme inhibitors

A. Tebben, B. W. King, M. Covington, 2007 .

Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.

David S. Nirschl, David S Nirschl, A. Doweyko, 2013, Bioorganic & medicinal chemistry letters.

The design and synthesis of sulfonamides as caspase-1 inhibitors.

J. Dunbar, N. Walker, W. Harter, 2004, Bioorganic & medicinal chemistry letters.

Rapid SERS Quantification of Trace Fentanyl Laced in Recreational Drugs with a Portable Raman Module.

L. Fabris, J. Gilmore, Hao Wang, 2021, Analytical chemistry.

Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P1) Modulator Advanced into Clinical Trials.

Michael G. Yang, K. McIntyre, D. Shen, 2019, Journal of medicinal chemistry.

Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).

Michael A. Galella, K. McIntyre, D. Shen, 2016, Journal of medicinal chemistry.

Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P1 Receptor Modulator.

Michael G. Yang, K. McIntyre, D. Shen, 2016, Journal of medicinal chemistry.

Preparation of an autolysis-resistant interleukin-1 beta converting enzyme mutant.

J. Mankovich, R. Talanian, M. Hackett, 1996, Biochemistry.

Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.

A. Doweyko, J. Barrish, S. Nadler, 2013, Bioorganic & medicinal chemistry letters.

Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.

M. Emmerling, J. Jaén, R. Nath, 1999, Bioorganic & medicinal chemistry letters.

2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.

M. Emmerling, J. Jaén, K. Raser, 1998, Journal of medicinal chemistry.

Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

M. Emmerling, J. Jaén, S. Hays, 1996 .

Cleavage of Oligonucleotides from Solid-Phase Supports Using o-Nitrobenzyl Photochemistry

M. Greenberg, J. Gilmore, 1994 .

Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).

Andrew Tebben, A. Tebben, C. Decicco, 2007, Bioorganic & medicinal chemistry letters.

Conversion of potent MMP inhibitors into selective TACE inhibitors.

Bryan W King, B. W. King, M. Covington, 2006, Bioorganic & medicinal chemistry letters.

Regioselective Epoxide Ring Opening for the Stereospecific Scale-Up Synthesis of BMS-960, A Potent and Selective Isoxazole-Containing S1P1 Receptor Agonist

A. Mathur, Zhiwei Guo, A. Goswami, 2017 .

154. The structure of aromatic compounds. Part III. The action of acetyl chloride on α and β-naphthylmethylmagnesium halides

J. Gilmore, N. Campbell, W. Anderson, 1940 .

Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).

John Roderick, Xiao-tao Chen, M. Covington, 2007, Bioorganic & medicinal chemistry letters.

Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

J. Trzăskos, T. Maduskuie, B. W. King, 2004 .

Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.

K. McIntyre, D. Shuster, D. Shen, 2016, Journal of medicinal chemistry.

96. The structure of aromatic compounds. Part II

J. Gilmore, N. Campbell, W. Anderson, 1940 .

Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P1) Modulators: Optimization of the PK, PD, and Safety Profiles.

Michael G. Yang, K. McIntyre, D. Shen, 2020, ACS medicinal chemistry letters.